BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 17103197)

  • 1. Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings.
    Cohen L; de Moor CA; Eisenberg P; Ming EE; Hu H
    Support Care Cancer; 2007 May; 15(5):497-503. PubMed ID: 17103197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
    Hilarius DL; Kloeg PH; van der Wall E; van den Heuvel JJ; Gundy CM; Aaronson NK
    Support Care Cancer; 2012 Jan; 20(1):107-17. PubMed ID: 21258948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
    Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
    J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes.
    Liau CT; Chu NM; Liu HE; Deuson R; Lien J; Chen JS
    Support Care Cancer; 2005 May; 13(5):277-86. PubMed ID: 15770489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a U.S. population.
    Haiderali A; Menditto L; Good M; Teitelbaum A; Wegner J
    Support Care Cancer; 2011 Jun; 19(6):843-51. PubMed ID: 20532923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall.
    Martin AR; Pearson JD; Cai B; Elmer M; Horgan K; Lindley C
    Support Care Cancer; 2003 Aug; 11(8):522-7. PubMed ID: 12827483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
    Molassiotis A; Aapro M; Dicato M; Gascon P; Novoa SA; Isambert N; Burke TA; Gu A; Roila F
    J Pain Symptom Manage; 2014 May; 47(5):839-848.e4. PubMed ID: 24075401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed nausea and vomiting from carboplatin doublet chemotherapy.
    Waqar SN; Mann J; Baggstrom MQ; Waqar MA; Chitneni P; Williams K; Gao F; Morgensztern D; Govindan R
    Acta Oncol; 2016 Jun; 55(6):700-4. PubMed ID: 27145068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre.
    Warr JK; Chambers CR; Cusano FL; Cuthbert CA; Mah MS
    J Oncol Pharm Pract; 2015 Oct; 21(5):348-57. PubMed ID: 24938292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of chemotherapy-induced nausea and vomiting on health-related quality of life.
    Ballatori E; Roila F; Ruggeri B; Betti M; Sarti S; Soru G; Cruciani G; Di Maio M; Andrea B; Deuson RR
    Support Care Cancer; 2007 Feb; 15(2):179-85. PubMed ID: 16941136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States.
    Schwartzberg L; Morrow G; Balu S; Craver C; Gayle J; Cox D
    Curr Med Res Opin; 2011 Aug; 27(8):1613-22. PubMed ID: 21696263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Life Associated with Nausea and Vomiting from Anthracycline-Based Chemotherapy: A Pooled Data Analysis from Three Prospective Trials.
    Yeo W; Mo FKF; Yip CCH; Yeo VA; Li L; Lau TKH; Lai KT; Chan VTC; Wong KH; Pang E; Cheung M; Chan V; Kwok CCH; Suen JJS; Molassiotis A
    Oncologist; 2021 Dec; 26(12):e2288-e2296. PubMed ID: 34516038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life.
    Abunahlah N; Sancar M; Dane F; Özyavuz MK
    Int J Clin Pharm; 2016 Dec; 38(6):1464-1476. PubMed ID: 27796777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice.
    Kim HK; Hsieh R; Chan A; Yu S; Han B; Gao Y; Baños A; Ying X; Burke TA; Keefe DM
    Support Care Cancer; 2015 Jan; 23(1):293-300. PubMed ID: 25142702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries.
    Hsieh RK; Chan A; Kim HK; Yu S; Kim JG; Lee MA; Dalén J; Jung H; Liu YP; Burke TA; Keefe DM
    Support Care Cancer; 2015 Jan; 23(1):263-72. PubMed ID: 25120009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers.
    Ihbe-Heffinger A; Ehlken B; Bernard R; Berger K; Peschel C; Eichler HG; Deuson R; Thödtmann J; Lordick F
    Ann Oncol; 2004 Mar; 15(3):526-36. PubMed ID: 14998860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed.
    Erazo Valle A; Wisniewski T; Figueroa Vadillo JI; Burke TA; Martinez Corona R
    Curr Med Res Opin; 2006 Dec; 22(12):2403-10. PubMed ID: 17257454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study.
    Grassi L; Berardi MA; Ruffilli F; Meggiolaro E; Andritsch E; Sirgo A; Caruso R; Juan Linares E; Bellé M; Massarenti S; Nanni MG;
    Psychother Psychosom; 2015; 84(6):339-47. PubMed ID: 26402426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.
    Grunberg SM; Deuson RR; Mavros P; Geling O; Hansen M; Cruciani G; Daniele B; De Pouvourville G; Rubenstein EB; Daugaard G
    Cancer; 2004 May; 100(10):2261-8. PubMed ID: 15139073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life.
    Fernández-Ortega P; Caloto MT; Chirveches E; Marquilles R; Francisco JS; Quesada A; Suárez C; Zorrilla I; Gómez J; Zabaleta P; Nocea G; Llombart-Cussac A
    Support Care Cancer; 2012 Dec; 20(12):3141-8. PubMed ID: 22460057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.